Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that targeting 5α-reductase, the androgen receptor, and hair growth genes, along with using compounds with anti-androgenic properties, could lead to more effective hair loss treatments.

High levels of testosterone and 5α-DHT can lead to cell death in cells important for hair growth.

Androstanediol glucuronide is a reliable marker for hirsutism in women.

Androgen conjugates might be better indicators of skin sensitivity to hormones in women with excessive hair growth.

LY191704 is a compound that effectively blocks a specific enzyme involved in hormone conversion and could help treat enlarged prostate and hair loss.

The document concludes that Nonclassic Congenital Adrenal Hyperplasia requires personalized treatment plans to manage symptoms and fertility, with glucocorticoids being a common therapy.

Selective non-steroidal inhibitors of 5α-reductase type 1 can help treat DHT-related disorders.

The document concludes that research on sulfatase inhibitors should continue due to their potential in treating various diseases, despite some clinical trial failures.

To diagnose Polycystic Ovarian Syndrome, two out of three signs—irregular periods, high male hormone levels, or cysts on the ovaries—are needed.

The enzyme 17β-HSD type 2 mainly performs oxidation in human sebaceous glands, which may help protect against acne.

Excessive hair growth can be assessed by history, exam, and blood tests, and treated with medication like dexamethasone, birth control pills, and spironolactone.

Finasteride and flutamide effectively reduce hirsutism in PCOS women, with flutamide also lowering hormone levels.

A natural steroid in the body may protect against eye damage in glaucoma.

Certain HSD3B1 gene types are linked to worse prostate cancer outcomes and affect treatment response and other health conditions.

SHBG binding properties are unchanged in male liver cirrhosis patients.

Finasteride lowers scalp and blood DHT levels, potentially treating male-pattern baldness.

Testosterone therapy aims to treat hormone deficiencies and various conditions safely and effectively, but requires careful patient monitoring due to potential side effects.

Male rats have androgen receptors in their liver, which are different from proteins that bind estrogen.

Cyclodextrins improve how steroid drugs work and are used in marketed medications and environmental applications.

Most hirsutism cases are due to PCOS, and treatment focuses on lowering testosterone and blocking its effects.

5α-Reductase inhibitors can help treat hair loss, acne, and prostate issues by reducing DHT levels.

Different halogens on progesterone derivatives can either block or mimic male hormone effects, depending on their type and amount.

The study found that urine metabolites M1b or M4 are the best indicators of ATD use in horses, with detection possible up to 77 hours in urine and 28 hours in blood.

The document concludes that low-dose oral contraceptives and hormonal therapies can manage perimenopause symptoms and reduce some health risks, but lifestyle changes and disease screening are also important.

Researchers developed a model to predict how well certain compounds can block an enzyme related to hair loss and prostate issues, suggesting a 50 mg dose of finasteride might be effective based on lab and body data.

FCE 28260 is a stronger and longer-lasting inhibitor of 5α-reductase than finasteride, which may make it a better treatment for certain medical conditions.

Activating TSPO helps protect the retina from damage caused by high eye pressure in glaucoma.

New treatments for excessive hair growth in women include insulin modulators and enzyme inhibitors.

The conclusion is that young women with excessive hair growth should be quickly tested for hormonal issues and treated to improve their social well-being.

Iron oxide nanoparticles improve skin penetration and drug release for hair loss treatment.